ANVS
#4225
Annovis Bio, Inc. Common Stock
1.7 8 USD
+0.05%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+4.71%
Variación mensual
-0.56%
Variación en los últimos 6 meses
-44.72%
Cambio anual
-34.32%
Cierres anteriores
1.7 0
Open
1.7 3
Mínimo
1.7 1
High
1.7 8
Volumen
56
Financials
- Market Capitalization 61.67 M
- Employee 7
- Founded 2008
- CEO Maria-luisa Maccecchini
- Website www.annovisbio.com
- Headquarter Delaware, United States
- FIGI BBG00PN9XD40
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4217 |  OKYO OKYO Pharma Limited - American Depositary Shares | 1.59 USD | +0.63% | -11.67% | +1.27% | -47.00% | 59.80 M USD | ||
| 4219 |  ELTX Elicio Therapeutics, Inc. - Common Stock | 3.03 USD | -2.57% | -5.61% | -25.37% | -69.70% | 57.83 M USD | ||
| 4240 |  CNTX Context Therapeutics Inc. - Common Stock | 0.62 USD | 0.00% | -10.14% | -11.43% | -19.48% | 56.97 M USD | ||
| 4242 |  INKT MiNK Therapeutics, Inc. - Common Stock | 10.90 USD | -4.47% | +0.28% | -13.22% | -0.91% | 54.30 M USD |